Yayın:
Anticancer and antituberculosis effects of 5-fluoro1H-indole-2,3-dione 3-thiosemicarbazones

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDikmen, Miriş
dc.contributor.authorCANTÜRK, ZERRİN
dc.contributor.authorMiriş Dikmen
dc.contributor.authorNilgün Karalı
dc.contributor.orcid0000-0001-7821-6854
dc.contributor.orcid0000-0001-7709-4285
dc.contributor.orcid0009-0000-1090-0166
dc.contributor.orcid0000-0002-6916-122X
dc.date.accessioned2025-11-13T20:27:59Z
dc.date.issued2020-12-30
dc.identifier.doihttps://doi.org/10.26650/istanbuljpharm.2020.0086
dc.identifier.issn2548-0731
dc.identifier.issue3
dc.identifier.openalexW3118425851
dc.identifier.urihttps://hdl.handle.net/11421/11881
dc.identifier.urihttps://doi.org/10.26650/istanbuljpharm.2020.0086
dc.identifier.volume50
dc.language.isoen
dc.relation.ispartofIstanbul Journal of Pharmacy
dc.rightsopenAccess
dc.subjectCytotoxic T cell
dc.subjectCell culture
dc.subjectChemistry
dc.subjectMTT assay
dc.subjectCisplatin
dc.subjectIndole test
dc.subjectCytotoxicity
dc.subjectCell
dc.subjectStereochemistry
dc.subjectIn vitro
dc.subjectBiology
dc.subjectBiochemistry
dc.subjectChemotherapy
dc.titleAnticancer and antituberculosis effects of 5-fluoro1H-indole-2,3-dione 3-thiosemicarbazones
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5042645402
local.authorid.openalexA5085224535

Dosyalar

Koleksiyonlar

Publications